RETA Quote, Trading Chart, Reata Pharmaceuticals Inc.
home / stock / reta / reta quote
$129.53 Last:
-4.35% Change Percent:
$135 Open:
$129.53 Previous Close:
$135 High:
$128.01 Low:
520,770 Volume:
06/04/2020 04:26:22 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2020-06-04 | 135 | 129.53 | 135 | 128.01 | 520,770 |
| 2020-06-03 | 140.96 | 135.42 | 142.79 | 134.01 | 424,552 |
| 2020-06-02 | 140.56 | 140.33 | 141.155 | 134.68 | 328,320 |
| 2020-06-01 | 143.97 | 139.91 | 145.93 | 139.33 | 273,588 |
| 2020-05-29 | 148.06 | 145.32 | 148.26 | 139.62 | 392,807 |
| 2020-05-28 | 152.5 | 147.24 | 154.46 | 146.5 | 201,457 |
| 2020-05-27 | 159.5 | 152.78 | 160 | 146.465 | 335,104 |
| 2020-05-26 | 163.26 | 157.76 | 163.98 | 157.3 | 176,315 |
| 2020-05-25 | 158.94 | 160 | 161.1853 | 156.205 | 111,907 |
| 2020-05-22 | 158.94 | 160 | 161.1853 | 156.205 | 110,672 |
| 2020-05-21 | 158.36 | 158.36 | 159.4002 | 152.62 | 221,755 |
| 2020-05-20 | 152 | 157.26 | 160.065 | 150.61 | 200,517 |
| 2020-05-19 | 151.34 | 150 | 155.84 | 150 | 195,152 |
| 2020-05-18 | 160.46 | 152.83 | 162.36 | 152.54 | 206,469 |
| 2020-05-15 | 154.42 | 154.77 | 156 | 150.12 | 191,653 |
| 2020-05-14 | 146.99 | 153.53 | 155.98 | 146.13 | 220,391 |
| 2020-05-13 | 165.33 | 150.54 | 165.5 | 146.73 | 410,569 |
| 2020-05-12 | 160 | 165.54 | 176.53 | 160 | 454,316 |
| 2020-05-11 | 162.13 | 164.31 | 166.63 | 160.44 | 421,351 |
| 2020-05-08 | 163.25 | 162.23 | 163.81 | 159.64 | 276,299 |
Reata Pharmaceuticals Inc. Company Name:
RETA Stock Symbol:
NASDAQ Market:
Reata Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
Image source: The Motley Fool. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) Q1 2020 Earnings Call May 11, 2020 , 4:30 p.m. ET Operator Continue reading
-
Reata Pharmaceuticals, Inc. (RETA) Q1 2020 Earnings Conference Call May 11, 2020, 16:30 ET Company Participants Vineet Jindal - VP, Corporate Communications & Strategy Colin Meyer - Chief Medical Officer & EVP, Product Development Manmeet Soni - CFO & EVP Warren Huf...
-
Reata Pharmaceuticals (NASDAQ: RETA ): Q1 Non-GAAP EPS of -$0.89; GAAP EPS of -$1.47 beats by $0.52 . More news on: Reata Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Direct Branding and Market Awareness
